Literature DB >> 12117042

Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD--a 1-year follow-up randomized, controlled trial.

Frode Gallefoss1, Per Sigvald Bakke.   

Abstract

The aims were to explore the effects and health economic consequences of patient education in patients with COPD in a 12-month follow-up. Sixty-two patients with mild-to-moderate chronic obstructive pulmonary disease (COPD) were at our outpatient clinic randomly allocated to an intervention group or a control group. The intervention group participated in a 4-h schooling, followed by one-to-two individual nurse and physiotherapist consultations. Self-management was emphasized following a stepwise treatment plan. Effectiveness was expressed in terms of proportions in need of general practitioner (GP) consultations, patient satisfaction and utilization of rescue medication. Doctor visits, days off work, dispensed pharmaceuticals, hospital admissions, travel costs, educational and time costs were recorded. The control and intervention groups induced mean total costs of NOK 19900 and 10600 per patient, respectively. The results were robustto realistic changes in the assumptions upon which they were based. For every NOK put into patient education, there was a saving of 4.8. The NNE to make one patient independent of their GP was 1.7 (95% CI: 1.3--2.8) and associated with a concomitant saving of NOK 15 800. The corresponding NNE to make one person satisfied with their GP was 4.5 (95% CI: 2.9--10) and NOK 41900, respectively. A reduced need of 100 DDD of rescue medication was associated with a concomitant saving of NOK5600. We conclude that patient education of patients with COPD in a 12-month follow-up improved patient outcomes and reduced costs.

Entities:  

Mesh:

Year:  2002        PMID: 12117042     DOI: 10.1053/rmed.2002.1293

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

Review 1.  Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.

Authors:  Anke Lenferink; Marjolein Brusse-Keizer; Paul Dlpm van der Valk; Peter A Frith; Marlies Zwerink; Evelyn M Monninkhof; Job van der Palen; Tanja W Effing
Journal:  Cochrane Database Syst Rev       Date:  2017-08-04

2.  Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).

Authors:  Maher R Khdour; Ahmed F Hawwa; Joseph C Kidney; Bronagh M Smyth; James C McElnay
Journal:  Eur J Clin Pharmacol       Date:  2012-04-05       Impact factor: 2.953

3.  Cost-utility analysis of a pharmacy-led self-management programme for patients with COPD.

Authors:  Maher R Khdour; Ashley M Agus; Joseph C Kidney; Bronagh M Smyth; James C McElnay; James C Elnay; Grainne E Crealey
Journal:  Int J Clin Pharm       Date:  2011-06-04

Review 4.  Tackling COPD: a multicomponent disease driven by inflammation.

Authors:  Peter Kardos; Joseph Keenan
Journal:  MedGenMed       Date:  2006-08-31

Review 5.  Patient Education Provided by Physiotherapists for Patients with Chronic Obstructive Pulmonary Disease: Results of a Scoping Review.

Authors:  Judy King; Sarah Tessier; Marie-Josée Charette; Danica Gaudet
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

6.  Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD).

Authors:  Basit Ahmad; Nina Ferrari; Georgina Montiel; Wilhelm Bloch; Anke Raabe-Oetker; Nina Skrobala; Klara Brixius
Journal:  Wien Med Wochenschr       Date:  2013-02-20

Review 7.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

Authors:  Denis E O'Donnell; Shaw Aaron; Jean Bourbeau; Paul Hernandez; Darcy D Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Rogers Goldstein; Rick Hodder; Alan Kaplan; Sean Keenan; Yves Lacasse; Francois Maltais; Jeremy Road; Graeme Rocker; Don Sin; Tasmin Sinuff; Nha Voduc
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409

Review 8.  Patient adherence in COPD.

Authors:  J Bourbeau; S J Bartlett
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

Review 9.  Estimating productivity costs using the friction cost approach in practice: a systematic review.

Authors:  Jesse Kigozi; Sue Jowett; Martyn Lewis; Pelham Barton; Joanna Coast
Journal:  Eur J Health Econ       Date:  2014-11-12

10.  Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain.

Authors:  Maureen P M H Rutten-van Mölken; Jan B Oostenbrink; Marc Miravitlles; Brigitta U Monz
Journal:  Eur J Health Econ       Date:  2007-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.